ABx Group has delivered solid progress across its heavy rare earths, hydrogen fluoride, and bauxite projects in Australia, highlighted by strong customer validation for rare earth samples and the start of pilot plant construction for its innovative fluorine chemical process.
- Positive feedback on rare earth carbonate samples from Australian and North American customers
- Expansion of exploration licences in northern Tasmania to over 800 km2
- Civil works underway for ALCORE hydrogen fluoride pilot plant with low-cost production potential
- Bauxite projects advancing through environmental approvals and investment milestones
- Cash reserves at AUD 600,000 with ongoing efforts to secure additional funding
Rare Earths Samples Win Early Customer Praise
ABx Group (ASX:ABX) has made notable strides in its rare earths program, distributing maiden mixed rare earth carbonate (MREC) samples from its Deep Leads resource in Tasmania to six potential customers across Australia and North America. The feedback has been overwhelmingly positive, with key players like Rare Earth Technologies Inc. and Ucore Rare Metals confirming the high purity and suitability of ABx’s product for advanced refining processes. The second MREC sample, produced via column leaching, boasts even higher concentrations of valuable heavy rare earths such as dysprosium and terbium, alongside significantly reduced impurities. This positions ABx favourably in a market where heavy rare earths face acute supply risks, particularly given China’s dominance in production.
Importantly, the Australian Nuclear Science and Technology Organisation (ANSTO) has confirmed that both MREC samples are exempt from radiological control, a crucial regulatory advantage that simplifies shipping and handling for customers. This low radioactivity level also means ABx is unlikely to require costly impurity removal steps, unlike many peers, potentially lowering production costs and enhancing customer appeal.
Exploration Footprint Expands in Tasmania
ABx’s portfolio in northern Tasmania has grown with the granting of Exploration Licence EL14/2025, adding 165 km2 and bringing the total tenement area prospective for ionic adsorption clay rare earth mineralisation to over 800 km2. The company is preparing for an exploration campaign starting August 2026, supported by artificial intelligence tools to integrate geological and metallurgical data for efficient target generation. This expansion underpins ABx’s strategy to grow its resource base and optimise project design ahead of commercial production.
ALCORE Pilot Plant Construction Advances in Bell Bay
On the fluorine chemicals front, ABx’s ALCORE subsidiary has commenced civil works for its continuous hydrogen fluoride pilot plant at the ALCORE Technology Centre in northern Tasmania. Equipment deliveries are ongoing, and major process modules are in manufacture, with formal hazard and operability (HAZOP) studies completed to support design finalisation. Indicative operating cost estimates suggest ALCORE’s process, which utilises aluminium smelter bath, a by-product with a growing global surplus, could produce anhydrous hydrogen fluoride (AHF) at costs US$400 per tonne lower than traditional acidspar methods, placing it in the lowest cost quartile worldwide.
This low-cost potential is significant given the critical role of fluorine chemicals in lithium-ion batteries, semiconductors, and aluminium smelting, and the global supply risks associated with fluorspar, the conventional feedstock. ALCORE’s pilot plant aims to validate commercial design parameters and produce saleable hydrogen fluoride, with strong backing from Rio Tinto and the Tasmanian Government.
Bauxite Projects Progress with Approvals and Investments
ABx’s bauxite projects are advancing steadily, supported by a $2.7 million investment from Good Importing International (GII) for a 70% stake in the Sunrise Bauxite Project in Queensland. Environmental approvals are on track for completion in 2027, with preliminary ecology studies and tender processes underway. Due diligence on the Taralga Project in New South Wales found no critical issues, paving a credible path to development. Meanwhile, the DL130 Bauxite Project in Tasmania awaits resolution of planning permit appeals, with mining leases already granted.
The company is targeting both metallurgical and refractory-grade bauxite for the aluminium, cement, and fertiliser industries, capitalising on recent price spikes driven by supply constraints. A supply agreement with Adelaide Brighton Cement Limited anticipates delivering 90,000 to 120,000 tonnes of cement-grade bauxite over five years, underscoring ABx’s focus on profitable, near-term production.
Financial Position and Funding Outlook
ABx reported net cash outflows from operating and investing activities of AUD 347,000 and AUD 1.2 million respectively for the quarter, ending with cash reserves of AUD 600,000. The company acknowledges funding runway of less than one quarter at current expenditure levels but highlights multiple options to extend this, including research and development tax incentives, potential strategic investments, and the flexibility to scale or delay exploration activities. Ongoing discussions with prospective investors aim to secure additional capital to support project development.
Environmental and regulatory processes remain on schedule across all projects, with no critical issues identified in recent due diligence. ABx’s integrated approach across rare earths, fluorine chemicals, and bauxite mining positions it to contribute to critical minerals supply chains amid increasing global demand and supply constraints.
Bottom Line?
ABx’s simultaneous progress in rare earths, fluorine chemical innovation, and bauxite mining underscores its multifaceted approach to critical minerals, but its near-term funding needs and regulatory hurdles will be pivotal to watch.
Questions in the middle?
- Will ABx secure additional funding to sustain its ambitious development programs beyond the current cash runway?
- How will customer qualification of the second MREC sample influence ABx’s rare earths commercialisation timeline?
- Can ALCORE’s pilot plant validate the cost advantages of using aluminium smelter bath at commercial scale?